Trials / Unknown
UnknownNCT04109872
Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is a multicentric, observational and retrospective study of the use of lenalidomide in patients with relapsed or refractory mantle cell lymphoma that are included in the RRMCL spanish program. The lenalidomide effectiveness and tolerability data will be retrospectely collected until the 30 of April 2018.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lenalidomide | Lenalidomide effectiveness and tolerability data analysis, that will be retrospectively collected until the 30 of April 2018. |
Timeline
- Start date
- 2018-09-15
- Primary completion
- 2020-06-15
- Completion
- 2020-07-15
- First posted
- 2019-10-01
- Last updated
- 2020-02-05
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04109872. Inclusion in this directory is not an endorsement.